The Latest Cardiac and Vascular News
STOCKHOLM, June 30, 2021 /PRNewswire/ — Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on interventional procedures, has entered into an agreement with Baylis Medical Company (“Baylis”) to provide simulation solutions. Based on this order, Mentice will […]
STOCKHOLM, Feb. 4, 2021 /PRNewswire/ — Strong order intake and substantial improvement of the company’s order book as well as operating cash flowFourth quarter (October-December 2020) Order intake amounted to 73.1 (54.7) MSEK. Net sales amounted to 45.9 (60.2) MSEK. Operating income for […]
STOCKHOLM, Jan. 13, 2021 /PRNewswire/ — Mentice AB (publ), a leading supplier of high-tech solutions for simulation in the medical sector, with focus on endovascular procedures, has announced changes to its organization. Several new key positions have been created, aimed at improving Mentice’s regional […]
STOCKHOLM, Dec. 4, 2020 /PRNewswire/ — Regarding the acquisition of the assets from Vascular Simulations Inc 571,974 shares have been issued at a subscription price of SEK 86.16 and regarding the acquisition of the assets from EQIP Inc, 9,469 shares have been issued at […]
– Combined portfolio will enhance Mentice’s endovascular simulation offerings with world class replication solutions – Acquisition to expand Mentice’s global customer base and offer a strong entry into previously untapped market segments STOCKHOLM, Oct. 1, 2020 /PRNewswire/ — Mentice AB (STO: MNTC) […]
Coronary Advanced to Help Fellows and Attending Interventional Cardiologists to Perfect Skills in Complex Scenarios STOCKHOLM, May 21, 2020 /PRNewswire/ — Mentice AB (STO: MNTC), a world leader in high-fidelity endovascular simulation introduces Coronary Advanced for select VIST® platforms. Following the introduction of […]
